Evidence map›Paper›PMID 19076351›Full record

ReviewAnnals of the New York Academy of Sciences2008

Regulation and function of proinflammatory TH17 cells.

Gustavo J Martinez, Roza I Nurieva, Xuexian O Yang, Chen Dong

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. CD4European journal of immunology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Revisiting Migraine Pathophysiology: from Neurons To Immune Cells Through Lens of Immune Regulatory Pathways.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Adipose tissue lymphocytes and obesity.The journal of cardiovascular aging · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gustavo J MartinezDepartment of Immunology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Roza I Nurieva
Xuexian O Yang
Chen Dong

Funding

Transcriptional regulation of inflammatory helper T Cell differentiationR01AR050772 · NIAMS · UNIVERSITY OF WASHINGTON · PI DONG, CHEN · 2003 to 2016
$4.5M
NIAMS NIH HHS R01 AR050772
6 · The paper itself

Abstract

Naïve CD4(+) helper T (TH) cells, upon activation by antigen-presenting cells (APC), differentiate into different types of effector cells that are characterized by their distinct cytokine production profiles and immune regulatory functions. In addition to TH1 and TH2 cells, a third subset of effector TH cells has recently been described and termed TH17. Since their identification, TH17 cells have emerged as crucial players in infectious, inflammatory, and autoimmune diseases, and cancer. In this review, we summarize the latest discoveries on the cytokine-mediated regulation and transcriptional programming of TH17 cells and their roles in different immune responses and diseases.

Indexed as

AnimalsAutoimmune DiseasesCell DifferentiationCell LineageHumansInflammationInterleukin-17Models, BiologicalNuclear Receptor Subfamily 1, Group F, Member 3PhenotypeReceptors, Retinoic AcidReceptors, Thyroid HormoneSTAT Transcription FactorsT-Lymphocytes, Helper-InducerTranscription, GeneticInterleukin-17Nuclear Receptor Subfamily 1, Group F, Member 3Receptors, Retinoic AcidReceptors, Thyroid HormoneRORC protein, humanSTAT Transcription Factors

Identifiers

PMID19076351
PMCPMC5793850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.